PG
The Procter & Gamble Company
NYSE · Consumer Defensive · Household & Personal Products · US
$146.63
−0.20%Year over year
Reported trailing growth
- Revenue
- +3.3%
- EBITDA
- -11.1%
- EBIT
- -3.4%
- EPS
- +1.0%
- Free cash flow
- +13.3%
- Operating cash flow
- +14.1%
Forward estimates
Based on analyst estimates
- Revenue
- +1.9%
- EBITDA
- +6.1%
- EPS
- +3.5%
Three-year CAGR
- Revenue
- +2.0%
- EBITDA
- -0.8%
- EBIT
- +2.9%
- Net income
- +3.1%
- EPS
- +3.6%
- Free cash flow
- +4.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026